Parametric Portfolio Associates’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | $22.9M | Buy |
255,247
+3,706
| +1% | +$333K | 0.01% | 873 |
|
2021
Q4 | $28.2M | Buy |
251,541
+246,915
| +5,338% | +$27.6M | 0.01% | 776 |
|
2021
Q3 | $582K | Buy |
4,626
+3,081
| +199% | +$388K | ﹤0.01% | 3034 |
|
2021
Q2 | $209K | Sell |
1,545
-54
| -3% | -$7.31K | ﹤0.01% | 3394 |
|
2021
Q1 | $217K | Buy |
+1,599
| New | +$217K | ﹤0.01% | 3845 |
|
2020
Q4 | – | Sell |
-3,224
| Closed | -$359K | – | 4033 |
|
2020
Q3 | $359K | Sell |
3,224
-1,668
| -34% | -$186K | ﹤0.01% | 3413 |
|
2020
Q2 | $548K | Buy |
+4,892
| New | +$548K | ﹤0.01% | 3221 |
|
2020
Q1 | – | Sell |
-2,384
| Closed | -$227K | – | 4025 |
|
2019
Q4 | $227K | Buy |
+2,384
| New | +$227K | ﹤0.01% | 3693 |
|
2019
Q3 | – | Sell |
-2,542
| Closed | -$223K | – | 4003 |
|
2019
Q2 | $223K | Buy |
+2,542
| New | +$223K | ﹤0.01% | 3697 |
|
2019
Q1 | – | Sell |
-5,479
| Closed | -$393K | – | 3980 |
|
2018
Q4 | $393K | Buy |
5,479
+1,651
| +43% | +$118K | ﹤0.01% | 3417 |
|
2018
Q3 | $367K | Buy |
3,828
+106
| +3% | +$10.2K | ﹤0.01% | 3553 |
|
2018
Q2 | $354K | Buy |
3,722
+1,247
| +50% | +$119K | ﹤0.01% | 3490 |
|
2018
Q1 | $217K | Sell |
2,475
-1,184
| -32% | -$104K | ﹤0.01% | 3738 |
|
2017
Q4 | $311K | Buy |
3,659
+606
| +20% | +$51.5K | ﹤0.01% | 3552 |
|
2017
Q3 | $264K | Buy |
+3,053
| New | +$264K | ﹤0.01% | 3741 |
|
2015
Q2 | – | Sell |
-2,742
| Closed | -$206K | – | 4002 |
|
2015
Q1 | $206K | Buy |
+2,742
| New | +$206K | ﹤0.01% | 3739 |
|
2014
Q3 | – | Sell |
-27,156
| Closed | -$1.39M | – | 3873 |
|
2014
Q2 | $1.39M | Sell |
27,156
-1,536
| -5% | -$78.8K | ﹤0.01% | 2423 |
|
2014
Q1 | $1.36M | Sell |
28,692
-2,790
| -9% | -$133K | ﹤0.01% | 2390 |
|
2013
Q4 | $1.37M | Sell |
31,482
-546
| -2% | -$23.7K | ﹤0.01% | 2400 |
|
2013
Q3 | $1.38M | Buy |
32,028
+4,149
| +15% | +$179K | ﹤0.01% | 2282 |
|
2013
Q2 | $969K | Buy |
+27,879
| New | +$969K | ﹤0.01% | 2456 |
|